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Abstract
Objective. GCA is a large- and medium-vessel arteritis characterized by a range of histological patterns of
vascular wall injury. The aim of this study was to immunologically characterize the various histological
patterns of GCA.
Methods. Thirty-five consecutive patients with biopsy-proven GCA and 15 normal controls were studied.
IL-8, IL-9, IL-9R, IL-17, IL-4, TGF-b and thymic stromal lymphopoietin expression was evaluated by
RT!PCR and immunohistochemistry on artery biopsy specimens. Confocal microscopy was used to char-
acterize the phenotypes of IL-9-producing and IL-9R-expressing cells. Five additional patients who had
received prednisone when the temporal artery biopsy was performed were also enrolled to evaluate the
effect of glucocorticoids on IL-9 and IL-17 expression.
Results. IL-17 overexpression was observed mainly in arteries with transmural inflammation and vasa
vasorum vasculitis. IL-9 overexpression and Th9 polarization predominated in arteries with transmural
inflammation and small-vessel vasculitis. The tissue expression of both IL-9 and IL-17 was correlated
with the intensity of the systemic inflammatory response. IL-4, TGF-b and thymic stromal lymphopoietin,
which are involved in the differentiation of Th9 cells, were overexpressed in arteries with transmural
inflammation and small-vessel vasculitis. IL-9R was also overexpressed in GCA arteries with transmural
inflammation and was accompanied by increased expression of IL-8.
Conclusion. Herein we provide the first evidence that distinct populations of potentially autoreactive T
cells, expressing different cytokines (Th17 vs Th9), characterize patients with particular histological sub-
sets of GCA and may thus contribute to the heterogeneity of tissue lesions observed in these patients.
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Rheumatology key messages
. Th9 cells are present in the inflamed arteries of GCA patients.
. Th9 and Th17 cells differently characterize different histological patterns of GCA.
. IL-9 is involved in the regulation of macrophage function in GCA.
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GCA is a large- and medium-vessel arteritis characterized
by a range of histological patterns of vascular wall injury.
The classic histological lesion of GCA is characterized by
the presence of transmural inflammation, with or without
giant cells [1]. However, in some cases inflammation
is restricted to the peri-adventitial small vessels [peri-
adventitial small-vessel vasculitis (SVV)] or to the vasa
vasorum [vasa vasorum vasculitis (VVV)] [2!4]. The pres-
ence of an immunological Th1/Th17 signature in classic
GCA has been previously demonstrated [5]; however, a
precise immunological characterization of the various
histological patterns in GCA is still lacking.
Depending on the cytokine milieu, naı̈ve CD4+ T
cells differentiate into specialized subsets, such as Th1,
Th2, Th9, Th17 or Treg, which are characterized by the
expression of lineage-specific transcription factors
and produce a repertoire of specific cytokines [6].
Th2-derived cytokines have been previously demon-
strated to be consistently absent in GCA [7, 8]. We have
recently shown, however, that IL-33 (a cytokine involved in
promoting the Th2 response) is overexpressed in the
inflamed arteries of GCA patients and is accompanied
by strong M2 polarization [9]. Furthermore, IL-33 has
recently also been associated with the secretion of
IL-9 by human CD4+ T cells isolated from peripheral
blood [10].
IL-9 is a multifunctional cytokine that modulates various
immune cell types, such as Treg cells, Th17 cells and
antigen-presenting cells [11]. IL-9 is produced by several
subsets of CD4+ T effector cells (e.g. Th17, Th2 and Treg
cells), but only Th9 cells seem to be characterized by
specific and potent production of IL-9 [11]. Th9 cells de-
velop from naı̈ve T cells in the presence of TGFb, IL-4 and
thymic stromal lymphopoietin (TSLP) and require PU-1 as
a specific transcription factor for their differentiation
[11, 12]. Although the functions of Th9 cells have not
been completely clarified, they seem to be involved in
several types of inflammatory disease in both mice and
humans [11]. Whether IL-9 and Th9 cells are involved in
the pathogenesis of GCA is not known. The aim of this
study was to evaluate the expression of IL-9 and Th9 cells
and IL-17 in patients with GCA in relation to the various
histological patterns. Here we report that a distinct
immunological polarization appears to characterize each
specific histological pattern of GCA. IL-9 and Th9, but not
Th17, polarization predominates in inflamed arteries
of GCA patients with inflammation restricted to the peri-
adventitial small vessels. Conversely, a more intense Th17
polarization with weak IL-9 expression predominates in
GCA arteries with inflammation restricted to the vasa
vasorum. Finally, a concomitant strong Th9 and Th17 re-
sponse was observed in the more inflamed arteries dis-
playing transmural inflammation and especially in those
arteries with a granulomatous reaction. Our results might
imply certain pathogenic aspects for particular histo-
logical subsets of GCA.
Patients and methods
Patients
Forty consecutive patients (25 women, 15 men) with
biopsy-proven GCA were studied. Of these, 35 patients
were untreated at the time of artery biopsy. To assess the
effect of glucocorticoids on IL-9 and IL-17 expression,
artery samples from five patients who had received pred-
nisone (1 mg/kg per day) for an average of 21 days (range
8!33) when the temporal artery biopsy was excised were
also considered for this study. Patients with prior or cur-
rent diagnosis of cancer, autoimmune disease other than
GCA, or chronic infection were carefully excluded. The
median age of GCA patients was 71 years (range: 59!85
years) and median ESR was 51.8 mm/h (range: 10!110).
Headache and artery tenderness and/or decreased or
absent temporal artery pulsation were present in 31 of
40 patients. At the time of diagnosis, 8 patients had
vision loss, and PMR was associated in 17 patients.
After GCA diagnosis, in untreated patients prednisone
was commenced at a starting dosage of 50 mg/day and
then tapered in all patients according to the same fixed
schedule after 1 month of therapy if symptoms had
resolved. Biopsy specimens were evaluated by two
experienced pathologists with an expertise in vasculitides
(A.R. and A.C.) who had no access to clinical data. The
length of the temporal artery biopsy specimens was
50.5 cm in all cases. After histological review, biopsy
specimens were classified into one of the following three
categories according to the criteria defined in a recent
article by our group [2]: biopsy specimens with classic
GCA (with histological evidence of transmural infiltration,
predominantly of lymphomononuclear cells, with or with-
out giant cells); biopsy specimens with SVV surrounding
an uninflamed temporal artery; and biopsy specimens
with VVV in the adventitia as the only lesion observed in
the temporal artery. Four parameters (score range 0!4), as
described by Hernández-Rodrı́guez J et al. [13], were
used to evaluate the baseline inflammatory response at
the time of diagnosis: fever, weight loss, an ESR of
585 mm/h and a haemoglobin level <11.0 mg/dl.
Patients were considered to have a weak inflammatory
response if they had two or fewer inflammatory param-
eters, and a strong inflammatory response if three or
four parameters were present. The controls comprised
15 histologically normal temporal artery samples from 15
consecutive patients (10 women, 5 men; median 74 years,
range: 60!84 years) with suspected GCA but with nega-
tive biopsy results. The ultimate diagnoses in these pa-
tients were: fever of unknown origin (five patients),
isolated PMR (five patients), non-specific headache in
the presence of OA (five patients). This study was
approved by the Ethics Committee of the University
of Palermo. Signed informed consent for the collection
and storage of biological material was also obtained
from all the patients enrolled in this study. All patients
gave their informed consent before enrolment into the
study.
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Immunohistochemical analysis of GCA biopsy
samples
Tissue samples were immediately fixed with 4% formal-
dehyde and embedded in paraffin. Immunohistochemistry
was performed on 5-mm!thick paraffin-embedded sec-
tions from arteries and from tonsils used as positive con-
trols, as previously described [9]. A list of primary
antibodies is provided in Table 1. The number of immu-
noreactive cells was determined by counting positively
stained cells on photomicrographs obtained from three
random high-power microscopic fields (!400 magnifica-
tion) under a Leica DM2000 optical microscope using a
Leica DFC320 digital camera (Leica, Rijswijk, The
Netherlands). Staining was semi-quantitatively scored on
a four-point scale (range: 0!3) at !200 magnification as
previously described [14]: score of 0 = no or minimal stain-
ing, score of 1 = up to 40% positive cells, score of
2 = 40!60% positive cells and score of 3 = staining of
>60% of the cells. Double staining was performed on
paraffin-embedded sections of arteries in order to char-
acterize Th9 cells and IL-9R-expressing cells. Sections
were incubated with primary anti-human IL-9 and PU.1
antibodies (Th9 cells), IL-9 and IL-17 (Th17 cells), and
IL-9R and CD15 (neutrophils), then treated with FITC- or
rhodamine red!conjugated anti-rabbit or anti-mouse anti-
bodies plus RNasi (200 mg/ml) and counterstained using
Toto-3 iodide (642/660; Invitrogen). Confocal analysis was
used to acquire fluorescence staining.
RNA extraction from artery biopsies and quantitative
TaqMan RT!PCR
Temporal artery biopsies prepared soon after removal
were also stored in RNAlater solution (Applied
Biosystems, Foster City, CA, USA). For quantitative
TaqMan real-time PCR, sets of primers and probes were
obtained from Applied Biosystems and are listed in
Table 1. Samples were run in triplicate using the Step-
One Real-Time PCR System (Applied Biosystems).
Relative changes in gene expression between controls
and patients were determined using the ""ct method,
using GAPDH to normalize target gene levels in each
sample as previously described [9]. Final values were ex-
pressed as relative expression between patients and
controls.
Statistical analysis
Statistical analysis of quantitative variables was per-
formed using the Mann!Whitney rank-sum test.
Pearson’s correlation analysis was utilized to quantify
the expression associations between the genes of inter-
est. P< 0.05 was considered significant.
Results
Histological characterization
Classic transmural inflammation was observed in 23 GCA
patients (12 with giant cells and granulomatous reaction).
SVV was observed in 10 patients and VVV in 7. None of
the GCA patients, regardless of the histologic phenotype,
had clinical manifestations suggesting a systemic vascu-
litis other than GCA when temporal artery biopsy was per-
formed or during the follow-up period (median 18 months,
range 8!33 months). All but the 9 patients with transmural
inflammation, 7 of the 10 patients with SVV, and 3 of the
VVV patients had a weak inflammatory response (two or
fewer inflammatory parameters). No differences between
the three histological groups were observed with respect
to the time from onset of symptoms to diagnosis.
IL-17 overexpression predominates in arteries with
transmural inflammation and VVV
IL-17 has previously been demonstrated to be involved in
the pathogenesis of GCA [5]. In our series, a significant
IL-17 overexpression was present in the arteries with
transmural inflammation (Fig. 1A and B) and was more
pronounced in those displaying granulomatous reaction
(Fig. 1A and B) compared with those without granuloma
(Fig. 1C). Significant IL-17 immunoreactivity was also
observed in the arteries of GCA patients with VVV
(Fig. 1D), was virtually absent in SVV (Fig. 1E), and was
never observed in normal controls (Fig. 1F; Fig. 1G shows
isotype control staining). Expression of IL-17 in arteries
TABLE 1 List of antibodies and primers used
Antibodies Source Primers
Rabbit polyclonal anti-human IL-8 Novus Biological, Littleton CO; 1:100 IL-9 (Hs00914237_m1)
Monoclonal mouse anti-human IL-9 Novus Biological, Littleton CO; 1:200 IL-9R (Hs01108522_m1)
Rabbit polyclonal anti-human IL-17 Sigma Aldrich, St Louis, MO; 1:250 IL-4 (Hs00174122_m1)
Rabbit polyclonal anti-human IL-9R Novus Biological, Littleton CO; 1:100 IL-17A (Hs00174383_m1)
Rabbit polyclonal anti-human IL-4 AbCam, Cambridge, UK; 1:250 TSLP (Hs00263639_m1)
Rabbit polyclonal anti-human TGF-b AbCam, Cambridge, UK; 1:250 TGF-b (Hs00998133_m1)
Rabbit polyclonal anti-human TSLP AbCam, Cambridge, UK; 1:250 GAPDH (Hs99999905_m1)
Mouse IgG1 monoclonal antibody AbCam, Cambridge, UK
Rabbit IgG polyclonal antibody AbCam, Cambridge, UK
Rabbit polyclonal anti-human PU.1 AbCam, Cambridge, UK
Mouse monoclonal anti-human CD15 Dako, Glostrup, Denmark
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with transmural inflammation and VVV was confirmed by
RT!PCR (Fig. 1H). In patients with transmural inflamma-
tion and VVV, the highest scores for IL-17 expression were
associated with the highest numbers of inflammation par-
ameters as described in the Patients and methods section
(Fig. 1I).
Th9 polarization predominates in arteries with
transmural inflammation and SVV
Various patterns of IL-9 expression were observed in GCA
patients. Significantly higher IL-9 expression character-
ized temporal arteries with classic transmural inflamma-
tion, independent of the presence of granuloma
(Fig. 2A!C) or SVV (Fig. 2E). Conversely, in VVV IL-9 was
only weakly expressed (Fig. 2D), and it was virtually
absent in normal controls (Fig. 2F; Fig. 2G shows isotype
control staining). Inflammatory cells infiltrating the artery
wall and giant cells, where present, were positive for IL-9
immunostaining (Fig. 2A!E). IL-9 positivity was also
observed in endothelial cells of vessels scattered through-
out the inflammatory infiltrates and among vascular
smooth muscle cells (VSMCs) (Fig. 2A!E). IL-9 tissue
expression was correlated with the intensity of the sys-
temic inflammatory response (Fig. 2H). Significantly
increased IL-9 expression was, in fact, observed in
patients with a strong versus those with a weak systemic
inflammatory response. IL-9 expression, in particular, cor-
related with acute-phase reactants, including ESR
(r = 0.4322, P = 0.002) and CRP concentration (r = 0.3435,
P = 0.003) (data not shown). IL-9 expression was also
evaluated by quantitative RT!PCR. As shown in Fig. 2I,
IL-9 was predominantly expressed in arteries with trans-
mural inflammation and SVV compared with VVV and
normal controls. In patients with transmural inflammation,
IL-9 expression was strongly and directly correlated
with IL-17 expression (Fig. 2J). Analysis of the tissue
distribution of IL-17- and IL-9-expressing cells in arteries
with transmural inflammation suggested a different
cellular source for these cytokines in the context of
mononuclear cells and an apparent co-localization with
giant cells. To better clarify the cellular source of IL-9-
producing cells, we also performed confocal microscopy
analyses. As shown in Fig. 2K!M, significant co-localiza-
tion was observed between IL-9 and PU.1, but not
FIG. 1 IL-17 expression in GCA
IL-17 expression in arteries with transmural inflammation and granulomatous reaction (A and B), with transmural
inflammation without granulomatous reaction (C), with VVV (D) and with SVV (E). (F) IL-17 expression in controls.
(H) m-RNA expression of IL-17 was assessed by quantitative RT!PCR in artery samples obtained from 17 GCA
patients and 10 control subjects. (I) Correlation between IL-17 semi-quantitative score systemic inflammatory response.
(B!E) Original magnification !250, (A, F and G) !100. (H) Data are expressed as mean (S.E.M.); *P< 0.05 compared with
SVV and NCs.
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between IL-9 and IL-17 (Fig. 2N!P), suggesting the pre-
valent Th9 phenotype of mononuclear IL-9-producing
cells. Interestingly, giant cells, occasionally scattered
throughout the inflamed arteries, showed an intense
co-expression of IL-9 and IL-17 (Fig. 2P).
IL-4, TGF-b and TSLP are overexpressed in GCA
arteries
Because of the intense tissue expression of IL-9, we also
evaluated the behaviour of IL-4, TGF-b and TSLP, which
are known to be involved in the modulation of IL-9
production [11, 12]. RT!PCR analysis demonstrated a sig-
nificant upregulation of TSLP (Fig. 3A) and TGF-b (Fig. 3E)
but not of IL-4 (Fig. 3I) in GCA arteries with transmural
inflammation and SVV compared with VVV and
control arteries. Immunohistochemical analysis, however,
demonstrated a significant overexpression of TSLP
(Fig. 3B!D), TGF-b (Fig. 3F!H) and IL-4 (Fig. 3J!L) in trans-
mural inflamed arteries and SVV compared with VVV and
controls (Fig. 3M!O shows isotype control staining for
TSLP, TGF-b and IL-4, respectively).
FIG. 2 IL-9 expression in GCA
IL-9 in arteries with transmural inflammation and granuloma (A and B), without granuloma (C), with VVV (D), with SVV (E)
and in controls (F). (G) Isotype control antibody staining. (H) IL-9 semi-quantitative score in arteries with transmural
inflammation (n = 23), SVV (n = 10) and VVV (n = 7) was correlated with the systemic inflammatory response. (I) m-RNA
expression of IL-9 in arteries from 17 GCA patients and 10 controls. (J) Correlation between IL-9 and IL-17 expression in
patients with transmural inflammation. (K!M) IL-9 (K) and PU.1 (L). (M) Merged double staining for IL-9 and PU.1. (N and
O) IL-9 (N) and IL-17 (O). (P) Merged double staining for IL-9 and IL-17. (A, F and G) original magnification!100; (B!E)
!250; (K!P) !400. (I) Data are expressed as mean (S.E.M.); *P< 0.05 compared with SVV and NCs.
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IL-9R is expressed mainly on the surface of
neutrophils and is accompanied by IL-8 expression
We also evaluated the expression of IL-9R. GCA arteries
with transmural inflammation displayed the more intense ex-
pression for IL-9R (Fig. 4A!C and E). By immunohistochem-
istry, IL-9R positivity was observed among VSMCs (Fig. 4B),
endothelial cells of vessels distributed in the inflammatory
infiltrates and cells with multinucleated nuclei strongly
resembling neutrophils (Fig. 4C). Significant infiltration by
neutrophils was confirmed by specific staining in patients
with transmural inflammation and by confocal microscopy
analysis (Fig. 4F!I), which showed that neutrophils are the
main IL-9R-expressing cell type in GCA arteries (Fig. 4I).
Since it is known that IL-9R activation in human neutrophils
results in IL-8 release [15], we next evaluated the expression
of IL-8 in arteries from GCA patients. IL-8 expression was
significantly modulated only in arteries with transmural
inflammation (Fig. 4J!L and N). Expression of IL-8 was
observed mainly among infiltrating mononuclear cells,
VSMCs and neovessels (Fig. 4K!L; D and M show isotype
control staining for IL-8 and IL-8R, respectively).
IL-9 expression is not modified by glucocorticoid
treatment
To analyse the effect of glucocorticoid therapy on IL-9 and
IL-17 expression, we compared their protein levels in
FIG. 3 IL-4, TGF-b and TSLP are overexpressed in GCA arteries
(A, E and H) m-RNA expression of TSLP (A), TGF-b (E) and IL-4 (I) in arteries obtained from GCA patients (7 with
transmural inflammation, 5 with VVV and 5 with SVV) and 10 controls. (B, C, F, G, J and K) Representative micro-
photographs showing TSLP (B and C), TGF-b (F and G) and IL-4 (J and K) immunostainings. (D, H and L) Quantification of
TSLP- (D), TGF-b! (H) and IL-4!(L) positive cells. (M and N) Isotype control staining for TSLP (M), TGF-b (N) and IL-4 (O).
(B, F and J) Original magnification !250, (C, G, K, M!O) !100. Data are expressed as mean (S.E.M.); *P< 0.05.
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arteries from five glucocorticoid-treated GCA patients.
As shown in Fig. 5, in glucocorticoid-treated arteries the
expression of IL-17 and the numbers of IL-17-immunore-
active cells was significantly decreased (Fig. 5A!C).
Conversely, there was no statistically significant reduction
in the numbers of IL-9!immunoreactive cells in specimens
obtained from glucocorticoid-treated patients (Fig. 5D!F).
Discussion
In GCA, two main cytokine pathways—the IL-6/IL-17 axis
and the IL-12/IFN-g axis—have been demonstrated to
play a prominent role in the pathogenesis of the vasculitic
process [16]. Yet the potential involvement of other cyto-
kine pathways and/or their expression correlated with par-
ticular histological patterns has not been adequately
studied. In this study, we evaluated the expression of
two cytokine pathways, IL-9/Th9 and IL-17/Th17, in vari-
ous histological subsets of GCA patients.
Distinct immunological signatures were observed in the
various subsets of GCA. IL-17 expression was observed
mainly in those arteries displaying granulomatous trans-
mural inflammation and VVV, and was virtually absent in
those with SVV. Conversely, intense IL-9 immunoreactivity
was observed in arteries with granulomatous transmural
inflammation and SVV, compared with arteries with VVV.
Interestingly, a strong co-expression of IL-9 and IL-17 was
observed in giant cells, highlighting the pro-inflammatory
role of these cells in GCA. The expression of both IL-9 and
IL-17 was strongly and directly correlated with the inten-
sity of the systemic inflammatory response, supporting a
prominent pro-inflammatory role for these cytokines. We
also evaluated the role of glucocorticoid treatment in the
expression of IL-9 and IL-17. Studies conducted on small
series have, in fact, previously shown that IL-17A-
expressing cells are dramatically reduced in specimens
obtained from glucocorticoid-treated patients [5, 17]. In
our study, IL-17 expression was significantly reduced by
glucocorticoid treatment, with IL-9 being only marginally
modified, indicating a potential role for Th9 cells in
glucocorticoid-resistant GCA.
In GCA arteries with transmural inflammation, IL-9-
expressing cells were to a large extent Th9 cells, since
they co-expressed the specific Th9 transcription factor
PU.1. Th9 cells are a distinct subpopulation of CD4+ ef-
fector T cells that preferentially secrete high levels of IL-9,
requiring TGF-b and IL-4 for their differentiation. These
cytokines induce expression of the transcription factors
FIG. 4 IL-9R is expressed on neutrophils in GCA arteries and accompanied by IL-8 overexpression
(A) m-RNA expression of IL-9R in arteries of GCA patients (7 with transmural inflammation, 5 with VVV and 5 with SVV)
and 10 controls. (B!D) Representative microphotographs showing IL-9R immunostainings in GCA (B and C) and controls
(D), with quantification of positive cells (E). (F!I) Single staining for IL-9R (F), CD15 (G) and toto-3 (H); (I) merged double
staining for IL-9R (green) and CD15 (red). (J) m-RNA expression of IL-8. (K!M) IL-8 immunostainings in GCA (K and L) and
controls (M), with quantification of IL-8!positive cells (N). (B, C, F!I, K and L) Original magnification !250; (D and M)
!100. Data are expressed as mean (S.E.M.); *P< 0.05.
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PU.1/Spi-1 and IFN regulatory factor 4, which subse-
quently regulate expression of the IL-9 gene [11]. More
recently, it has been demonstrated that Th9 cells also ex-
press greater amounts of the TSLP receptor than Th2
cells, and addition of TSLP to Th9 cultures increases
IL-9 production in vitro [12]. In our study, arteries with
higher expression of IL-9 (transmural inflammation with
granulomatous reaction and SVV) displayed intense
overexpression of IL-4, TGF-b and TSLP, suggesting
that the upstream Th9 cytokine network is also upregu-
lated in GCA. Interestingly, basal TSLP expression was
also observed in VSMCs of normal arteries, suggesting
constitutive expression of this cytokine in physiological
conditions. Despite the absence of IL-4 upregulation at
m-RNA level, IL-4 evaluation by immunohistochemistry
demonstrated its strong upregulation in inflamed arteries.
IL-9 expression was also accompanied by significant
overexpression of the specific IL-9 receptor on neutro-
phils. A potential role for neutrophils in GCA disease
progression has recently been hypothesized, providing
evidence of a role for neutrophil phenotypic changes in
GCA pathology [18]. Functional expression of IL-9R by
human neutrophils has been demonstrated in asthmatic
patients to have an important role in IL-8 release [15].
In this regard, high levels of IL-8 were observed in
GCA, especially in patients with transmural inflammation,
providing a functional immunological link between IL-9R
expression and neutrophil activity in GCA arteries.
Taken together, these findings seem to suggest the
relevance and functionality of the IL-9 axis and
highlight the importance of neutrophils in the pathogen-
esis of GCA.
In conclusion, in this study we confirmed a role for Th17
in the pathogenesis of GCA and for the first time demon-
strated a putative pro-inflammatory role for IL-9 and Th9
cells in the pathogenesis of GCA. We have also provided
the first evidence that distinct populations of potentially
autoreactive T cells expressing particular cytokines
(Th17 vs Th9) characterize patients with particular histolo-
gical subsets of GCA, and may thus contribute to the het-
erogeneity of tissue lesions observed in these patients.
The concomitant presence of a Th9 response may be
responsible for the chronicity of tissue damage with the
emergence of more severe tissue inflammation.
FIG. 5 Artery specimens from five GCA patients treated with glucocorticoids at the time of biopsy were evaluated for the
expression of IL-17 and IL-9
(A and B) Representative staining of IL-17 in arteries obtained from GC-treated patients. (C) Semi-quantitative analysis of
IL-17 expression in GC-treated arteries compared with untreated GCA arteries. (D!F) Representative stainings of IL-9 in
arteries obtained from GC-treated patients. (F) Semi-quantitative analysis of IL-9 expression in GC-treated arteries
compared with untreated arteries. (A, B, D and E) Original magnification !250. (C and F) Data are expressed as mean
(S.E.M.). GC: glucocorticoids.
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